How GLP-1 helps insulin sensitivity GLP-1 receptor agonists improve insulin sensitivity rapidly, often before any weight loss occurs
Recent preclinical studies have demonstrated that central GIP receptor activation can attenuate the aversive effects, such as nausea and vomiting, typically induced by GLP1 receptor agonism 29
When evaluating affordable GLP-1 choices, discussing your genetic and biomarker profile with a qualified healthcare provider can help identify which compounded formulation offers the best balance of cost and clinical potential
The absence of large controlled studies means this risk can't be quantified
Typically, shedding begins about 2-3 months after rapid weight loss starts and continues for about 3-6 months
[1] Additionally, gastrointestinal side effectsparticularly nausea, vomiting, and diarrheasometimes lead patients to reduce doses or skip injections, inadvertently limiting efficacy